Skip to main content
Not Found
Digital Seminar

Pediatric Psychopharmacology: Essential Information for Mental Health Professionals


Speaker:
David Dadiomov, PharmD, BCPP
Duration:
Approx. 6 Hours
Copyright:
Feb 22, 2024
Product Code:
POS059523
Media Type:
Digital Seminar - Also available: Live Webinar

Other great resources - exclusive savings when you add now!

Description

Treating kids on psychotropic medications is complex...

Keeping up to date on the ever-changing psychopharmacological recommendations. Staying abreast of potential side effects. Communicating with prescribers, parents, and school nurses.

It’s a LOT to juggle.

Dr. David Dadiomov, board certified clinical psychiatric pharmacist, author, and award-winning researcher, will give you the knowledge you need in this easy-to-understand, concise, and comprehensive training packed with practical strategies for working with children and teens.

Whether you’re prescribing, providing therapy, or working with kids on psychotropic medications in another capacity, you’ll leave with:

  • The confidence to answer medication-related questions from kids, teens, and parents
  • Must-know information about monitoring for reactions, symptom relief, and adverse side effects
  • Skills to effectively collaborate with prescribers, caregivers, and school nurses to ensure proper medication use for best results
  • Application of multidisciplinary ethics codes and real pediatric case examples

Purchase today for this critical course to ensure the best care possible for your young clients.

Credits


CE Information Coming Soon

Continuing education credit information is coming soon for this non-interactive self-study package.

CEs may be available for select professions, as listed in the target audience. Hours will be dependent on the actual recording time. Please check with your state licensing board or organization for specific requirements. 

There may be an additional fee for CE certificates. Please contact our Customer Service at 1-800-844-8260 for more details. 

**Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.



Speaker

David Dadiomov, PharmD, BCPP's Profile

David Dadiomov, PharmD, BCPP Related seminars and products


David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.

He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.

Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.

 

Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, the University of Southern California Psychiatry and Behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the College of Psychiatric and Neurologic Pharmacists, the American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.


Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info


Objectives

  1. Identify common concerns relating to medications and their impact on function for children and teens with mental health disorders.  
  2. Determine the role of professionals on the care team for clients who receive both psychotherapeutic medications and psychotherapy.  
  3. Identify ethical issues related to communicating with clients and prescribing professionals.  
  4. Determine the potential impact of medications on neurological development and function.  
  5. Categorize the major classes of drugs used to treat mental disorders to improve health management. 
  6. Identify adverse effects and drug reactions of the commonly prescribed psychotropic medications. 

Outline

Meds and Kids

  • What you need to know about psychiatric medications
  • Ethics guidelines
  • Top tips for talking with kids about their medications
  • Anticipate and address parents’ concerns
  • Coordinating care: prescriber, therapist, parents, school
  • Risks of off-label use and safety indications
  • Limitations of the research and potential risks

The Developing Nervous System

  • Organization of the nervous system
  • Communication between neurons
  • How medicines act differently in children
  • Genetics and environment impact
  • Potential impact of meds on neurological development

Depression, Anxiety, and Related Disorders

  • Differential pediatric diagnosis and the DSM-5®
  • SSRIs, SNRIs, Benzodiazepines
  • Benefits and adverse reactions in youth
  • Powerful combination: CBT + meds
  • Address concerns related to suicide risk with SSRIs
  • OCD treatment approaches
  • Case Study

Trauma and Adverse Childhood Experiences

  • Comorbid conditions in kids
  • Neurodevelopmental impact
  • Medications that can worsen PTSD outcomes
  • SSRIs for trauma
  • Case study

Behavior Disorder Medications

  • Monotherapy: pros and cons
  • Oppositional Defiant Disorder, Conduct Disorder, and Disruptive Mood Dysregulation Disorder
  • Lithium, anticonvulsants, and 2nd generation antipsychotics
  • Efficacy and side effects
  • Tips to increase medication compliance
  • Case study

ADHD Medications

  • Neurobiology and subtypes
  • Methylphenidate and amphetamine
  • Immediate vs extended release
  • Medication consistency and compliance: working with the school team
  • Addressing common parent concerns
  • Case study

Antipsychotic Medications

  • Psychosis symptoms in kids and teens
  • 1st and 2nd generation antipsychotics
  • Mechanism of action
  • Benefits and adverse reactions
  • Case study

Autism Spectrum Disorder

  • Brain differences in ASD
  • Co-occurring behaviors and conditions
  • Medications for autism-related behaviors
  • Efficacy and side effects
  • Case study

Other Neurodevelopmental Disorders

  • Tic disorders/Tourettes
  • Genetic disorders
    • Down Syndrome
    • Fragile X Syndrome
    • Klinfelter’s Syndrome
    • Prader-Willi Syndrome
  • Pharmacologic treatments

Eating Disorders

  • Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder
  • Neurobiology and pharmacologic treatments
  • Benefits and adverse reactions
  • Case study

Substance Use Disorders

  • Overview of drugs of misuse
  • Adverse effects and outcomes of using substances in adolescence
  • Harm reduction in substance use
  • Treatment of addiction disorders
    • Opioids (including fentanyl and counterfeit pills)
    • Marijuana
    • Stimulants (cocaine, methamphetamine)
    • Alcohol
    • Tobacco/vaping

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Case Managers
  • Nurse Practitioners
  • Physician Assistants
  • Occupational Therapists
  • Physicians
  • Addiction Counselors
  • Other Mental Health & Health Care Professionals

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of live webcasts and online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top